Testing effectiveness (Phase 2)UnknownNCT00045123What this trial is testingR-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of RecurrenceWho this might be right forProstate Cancer Myrexis Inc.
Large-scale testing (Phase 3)Study completedNCT00030654What this trial is testingHormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Looking for participantsNCT05726292What this trial is testingEnzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate CancerWho this might be right forProstate CancerProstate Adenocarcinoma University of Chicago 90
Testing effectiveness (Phase 2)Study completedNCT00487721What this trial is testingThe Effect of High-dose Silybin-phytosome in Men With Prostate CancerWho this might be right forProstate Cancer University of Colorado, Denver 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084What this trial is testingTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialWho this might be right forProstate Adenocarcinoma NRG Oncology 2,050
Not applicableActive Not RecruitingNCT04909294What this trial is testingEvaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate AdenocarcinomaWho this might be right forAdenocarcinoma of the Prostate Centre Georges Francois Leclerc 68
Large-scale testing (Phase 3)Active Not RecruitingNCT01368588What this trial is testingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Radiation Therapy Oncology Group 2,592
Testing effectiveness (Phase 2)Ended earlyNCT02140138What this trial is testingAn Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate CancerWho this might be right forProstate Carcinoma CureVac 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT04030559What this trial is testingNiraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response DefectsWho this might be right forATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+14 more Marc Dall'Era, MD 11
Testing effectiveness (Phase 2)Study completedNCT00071968What this trial is testingNeoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of RelapseWho this might be right forProstate Cancer Jonsson Comprehensive Cancer Center 15
Not applicableUnknownNCT00870714What this trial is testingNeoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot StudyWho this might be right forProstate Cancer Kansas City Veteran Affairs Medical Center 20
Not applicableStudy completedNCT00544336What this trial is testingFamily Quality of Life Among Families With a Member Who is a Cancer PatientWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+3 more Vanderbilt-Ingram Cancer Center 366
Testing effectiveness (Phase 2)Ended earlyNCT03432897What this trial is testingBrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair GenesWho this might be right forProstate CancerAdenocarcinoma of the Prostate Brown University 1
Testing effectiveness (Phase 2)Study completedNCT03617588What this trial is testing68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate CancerWho this might be right forProstate Cancer Theragnostics Ltd 49
Large-scale testing (Phase 3)Study completedNCT00329797What this trial is testingZoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone TherapyWho this might be right forOsteoporosisProstate Cancer Radiation Therapy Oncology Group 109
Not applicableLooking for participantsNCT06470750What this trial is testingFeasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)Who this might be right forProstate Adenocarcinoma Mayo Clinic 77
Not applicableStudy completedNCT01605097What this trial is testingHigh Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic NoduleWho this might be right forProstate Cancer British Columbia Cancer Agency 26
Testing effectiveness (Phase 2)Ended earlyNCT01499043What this trial is testingPilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)Who this might be right forProstate Cancer Daiichi Sankyo 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02949284What this trial is testingAndrogen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing SurgeryWho this might be right forStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma Rutgers, The State University of New Jersey 90
Early research (Phase 1)Study completedNCT00099086What this trial is testingDocetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate CancerWho this might be right forProstate Cancer Medical University of South Carolina 20